Definium Therapeutics, Inc. (DFTX) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 6.56 |
| Sector P/E (Healthcare) | 21.7 |
DFTX overview · DFTX earnings · DFTX KPIs · DFTX investor relations · DFTX ownership · DFTX peers · DFTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.